Omar Ragy

Has grant

Senior lecturer in clinical and medical education

Edge Hill University

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Immunology Immunology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Assessing the utility and cost-effectiveness of anti-PLA2R for diagnosing patients with membranous nephropathy in clinical practice: a systematic review and evidence synthesis study

Open Date: 2022-02-01

Close Date: 2023-05-03

Grant: Close

Using Biomarkers in developing Precision Medicine in Idiopathic Nephrotic Syndrome

Open Date: 2022-01-01

Close Date: 2023-12-01

Articles (11)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (3)

Farah E Latif

Clinical Lecturer

Cardiff University

UNITED KINGDOM

View details

Martin Gallagher

AUSTRALIA

View details

Patrick Hamilton

The University of Manchester

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Omar Ragy

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (11)

Time for a relook? An update on primary membranous nephropathy incidence in a large UK cohort

Time for a relook? An update on primary membranous nephropathy incidence in a large UK cohort

Thromboembolism in Nephrotic Syndrome: controversies and uncertainties

PLA2R antibody does not outperform conventional clinical markers in predicting outcomes in Membranous Nephropathy

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Can use of the serum anti-PLA2R antibody negate the need for a renal biopsy in primary membranous nephropathy?

Long-Term Safety, Clinical and Immunological Outcomes in Primary Membranous Nephropathy with Severe Renal Impairment Treated with Cyclophosphamide and Steroid-Based Regimen

Longitudinal Analysis of Prophylactic Anticoagulation in Primary Nephrotic Syndrome: Low Incidence of Thromboembolic Complications

Thromboembolism in nephrotic syndrome: controversies and uncertainties

PLA2R Antibody Does Not Outperform Conventional Clinical Markers in Predicting Outcomes in Membranous Nephropathy

Can use of the serum anti-PLA<sub>2</sub>R antibody negate the need for a renal biopsy in primary membranous nephropathy?

Collaborators (3)

Farah E Latif

Martin Gallagher

Patrick Hamilton

Make your next move.